Form SCHEDULE 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001641172-25-010946
Filing Date
2025-05-15
Accepted
2025-05-15 16:18:18
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html SCHEDULE 13G  
1 primary_doc.xml SCHEDULE 13G 11761
  Complete submission text file 0001641172-25-010946.txt   13946
Mailing Address 88 POST ROAD WEST 2ND FLOOR WESTPORT CT 06880
Business Address 88 POST ROAD WEST 2ND FLOOR WESTPORT CT 06880 212-624-2060
A.G.P. / ALLIANCE GLOBAL PARTNERS, LLC (Filed by) CIK: 0000318492 (see all company filings)

EIN.: 592015540 | State of Incorp.: NY | Fiscal Year End: 0630
Type: SCHEDULE 13G

Mailing Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL NORTH SUITE 200 NAPLES FL 34103 (646) 491 9132
CONDUIT PHARMACEUTICALS INC. (Subject) CIK: 0001896212 (see all company filings)

EIN.: 873272543 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SCHEDULE 13G | Act: 34 | File No.: 005-93313 | Film No.: 25953563
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)